(0.07%) 5 252.08 points
(-0.06%) 39 735 points
(0.00%) 16 399 points
(1.29%) $82.40
(1.16%) $1.738
(1.66%) $2 227.00
(0.20%) $24.80
(1.18%) $920.45
(0.21%) $0.925
(0.59%) $10.83
(0.00%) $0.791
(0.11%) $92.54
Live Chart Being Loaded With Signals
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology...
Stats | |
---|---|
Today's Volume | 109 095 |
Average Volume | 5 520.00 |
Market Cap | 8.20M |
EPS | $0 ( 2024-03-19 ) |
Next earnings date | ( $0 ) 2024-05-06 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.284 |
ATR14 | $0.878 (25.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-16 | Woods Robert Keith | Buy | 15 400 | Stock Option (Right to Buy) |
2024-01-16 | Palekar Rohan | Buy | 15 400 | Stock Option (Right to Buy) |
2024-01-16 | Noonberg Sarah B. | Buy | 15 400 | Stock Option (Right to Buy) |
2024-01-16 | Freedland Cory S. | Buy | 15 400 | Stock Option (Right to Buy) |
2024-01-16 | Baffi Robert | Buy | 15 400 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
75.17 |
Last 94 transactions |
Buy: 7 989 742 | Sell: 1 025 638 |
Volume Correlation
Neoleukin Therapeutics Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Neoleukin Therapeutics Correlation - Currency/Commodity
Neoleukin Therapeutics Financials
Annual | 2022 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-1.010 |
Q3 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.410 |
Q2 | 2023 |
Revenue: | $0 |
Gross Profit: | $0 (0.00 %) |
EPS: | $-0.190 |
Q1 | 2023 |
Revenue: | $0 |
Gross Profit: | $-3.42M (0.00 %) |
EPS: | $-1.810 |
Financial Reports:
No articles found.
Neoleukin Therapeutics
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators